occular drug delivery system
-
Upload
pratiksha-pratiksha -
Category
Health & Medicine
-
view
192 -
download
1
Transcript of occular drug delivery system
OCULAR DRUG DELIVERY
SYSTEM
Submitted by: Pratiksha Srivastava
M.Pharm(1st year)
Galgotias university
INTRODUCTION:- Ocular administration of drug is
primarily associated with the need to treat ophthalmic diseases.
Meant for local therapy and not for systemic action.
Applied topically to the cornea, or instilled in the space between the eyeball and lower eyelid
COMPOSITION OF EYE Water - 98% Solid -1.8% Organic element – Protein - 0.67% Sugar - 0.65% NaCl - 0.66% Other mineral element sodium, potassium and
ammonia - 0.79%.
D R U G I N T E A R F L U I D
Ocular Absorption (5% of the dose) Systemic Absorption
(50-100% of the dose)
Major Routes:
-Conjuctiva of eye -Nose
Minor Routes:
-Lacrimal Drainage -Pharynx -Aqueous Humor -Inner Ocular Tissues
Corneal Route:
-Primary Route.
-Small Lipophilic Drugs.
Conjunctival and Sclera Route:
-Secondary Route.
-Large Hydrophilic Drugs.
Aqueous Humor
Ocular Tissue Elimination
MECHANISM OF OCCULAR DRUG ABSORPTION
5
IDEAL CHARACTERISTIC Sterility
Isotonicity:
e.g.: 1.9% boric acid, 0.9% NaCl
Buffer/pH adjustment
Less drainage tendency
Minimum protein binding
OCULAR DELIVERY SYSTEMS
CONVENTIONAL
VESICULAR
CONTROL RELEASE
PARTICULATE
SOLUTIONSUSPENTIONEMULSIONOINTMENTINSERTGELS
IMPLANTS IONTOPHORESISDENDRIMERMICROEMULSIONNANOSUSPENSIONMICRONEEDLEMUCOADHESIVE POLYMERS
7
MICROPARTICLES
NANOPARTICLES
LIPOSOMESNIOSOMESDISCOMES
CLASSIFICATION OF OCDDS
CONVENTIONALEYE DROPS: Drugs which are active at eye or eye surface are widely
administered in the form of Solutions, Emulsion and
Suspension.
Various properties of eye drops like hydrogen ion
concentration, viscosity and instilled volume can influence
retention of a solution in the eye.
Less than 5 % of the dose is absorbed after topical
administration into the eye.
The dose is mostly absorbed to the systemic blood
circulation via the conjunctival and nasal blood vessels.
ADVANTAGES AND DISADVANTAGES OF EYE DROPS:Dosage form Advantages Disadvantages
Solutions 1. Convenience2. Usually do not interfere
with vision of patient.
1. Rapid precorneal elimination.
2. Non sustained action.3. To be Administered at
frequent intervals.
Suspension 1. Patient compliance.2. Best for drug with slow
dissolution.3. Longer contact time
1. Drug properties decide performance loss of both solutions and suspended particles.
2. Irritation potential due to the particle size of the drug.
Emulsion 1. Prolonged release of drug from vehicle
1. Blurred vision.2. patient non compliance.
10
OINTMENT: Prolongation of drug contact time with the
external ocular surface can be achieved using ophthalmic ointment vehicle.
Ointment base is sterilized by
heat and filtered while
molten to remove foreign
particulate matter.
It is then placed into a sterile
steam jacketed to maintain the ointment in a
molten state and excipients are
added
The entire ointment may
be passed through a previously sterilized
colloid mill
Advantages:1. Longer contact time and greater storage stability.2. Flexibility in drug choice.3. Improved drug stability.
Disadvantages:1. Sticking of eyes lids.2. Blurred vision.3. Poor patient compliance.4. Matting of eyelids.
VESICULAR:LIPOSOMES:- Liposomes are biocompatible and biodegradable lipid vesicles made up of
natural lipids and about
25 –100 nm in diameter.
They are having an intimate contact with the corneal and conjunctival
surfaces which is desirable for drugs that are poorly absorbed, the drugs
with low partition coefficient, poor solubility or those with medium to
high molecular weights and thus increases the probability of ocular drug
absorption.
Vesicle composed of phospholipid bilayer enclosing aqueous
compartment in alternate fashion.
It is Biodegradable, Non-toxic in nature.
ADVANTAGES
Drugs delivered intact to various
body tissues.
Liposomes can be used for both
hydrophilic and hydrophobic drug.
Possibility of targeting and
decrease drug toxicity.
The size, charge and other
characteristics can be altered
according to drug and desired
tissue.
DISADVANTAGES
They need many modification
for drug delivery to special
organs.
Stability problem and
oxidative degradation.
Requires special packaging
and storing facility.
Costly.
NIOSOMES AND DISCOMES They are non toxic and do not require special handling
techniques:• Niosomes are nonionic surfactant vesicles that have potential
applications in the delivery of hydrophobic or amphiphilic drugs.
• Discomes act as potential drug delivery carriers as they released drug in a sustained manner at the ocular site.
ADVANTAGES: The vesicles can act as a depot to release the drug slowly and
offer a controlled release.
They are osmotically active and stable.
They increase the stability of the entrapped drug.
Improves therapeutic performance of the drug by protecting it
from the biological environment and restricting effects to target
cells, thereby reducing the clearance of the drug.
NON ERODIBLE INSERTS:OCUSERT: The Ocusert therapeutic system is a flat, flexible, elliptical
device designed to be placed in the inferior cul-de-sac
between the sclera and the eyelid and to release Pilocarpine
continuously at a steady rate for 7 days.
The device consists of 3 layers.
1. Outer layer - ethylene vinyl acetate copolymer layer.
2. Inner Core - Pilocarpine gelled with alginate main polymer.
3. A retaining ring - of EVA impregnated with titanium dioxide.
• ADVANTAGES
Reduced local side effects and toxicity.
Around the clock control of drug.
Improved compliance.
• DISADVANTAGES
Retention in the eye for the full 7 days.
Periodical check of unit.
Replacement of contaminated unit
Expensive.
CONTACT LENS: Contact lenses can be a way of providing extended
release of drugs into the eye. Conventional hydrogel soft contact lenses have the
ability to absorb some drugs and release them into the post lens lachrymal fluid, minimizing clearance through the conjunctiva.
Their ability to be a drug reservoir strongly depends on the water content and thickness of the lens, the molecular weight of the drug, the concentration of the drug loading solution and the time the lens remains in it.
ERODIBLE INSERTS: The solid inserts absorb the aqueous tear fluid and
gradually erode or disintegrate. The drug is slowly
leached from the hydrophilic matrix.
They quickly lose their solid integrity and are squeezed
out of the eye with eye movement and blinking.
Do not have to be removed at the end of their use.
LACRISERTS Sterile rod shaped device made up of hydroxyl propyl cellulose
without any preservative. For the treatment of dry eye syndromes. It weighs 5 mg and measures 1.27 mm in diameter with a length
of 3.5 mm. It is inserted into the inferior fornix. SODI Soluble ocular drug inserts. Small oval wafer. Sterile thin film of oval shape. Weighs 15-16 mg. Use – glaucoma. Lacriserts
Minidisc
Countered disc with a convex front and a concave back surface.
Diameter – 4 to 5 mm.
Composition
Silicone based prepolymer (4-methacryloxy)-butyl poly di
methyl siloxane. (M2DX)
M-Methyl a cryloxy butyl functionalities.
D – Di methyl siloxane functionalities.
Pilocarpine, chloramphenicol.
Type Advantages Disadvantages
Erodible inserts
Effective.Flexiblility in drug type & dissolution rate.Need only be introduced into eye & not removed.
Patient discomfort.Requires patient insertion.
Non-erodible inserts
Controlled rate of release.Prolonged delivery.Flexibility for type of drug selected.Sustained release.
Patient discomfort.Irritation to eye.Tissue fibrosis.
Advantages And Disadvantages Of Ocular Inserts
1. Implants1. Implants have been widely employed to extend the release of
drugs in ocular fluids and tissues particularly in the posterior
segment.
2. Implants can be broadly classified into two categories based on
their degradation properties:
(1) Biodegradable
(2) Nonbiodegradable
Implants can be solids, semisolids or particulate-based delivery
systems.
For chronic ocular diseases like cytomegalo virus (CMV)
retinitis, implants are effective drug delivery system. Earlier non
biodegradable polymers were used but they needed surgical
procedures for insertion and removal. Presently biodegradable polymers such as Poly Lactic Acid
(PLA) are safe and effective to deliver drugs in the vitreous
cavity and show no toxic signs.
EVALUATION OF OCDDS
. Thickness of film2. Content uniformity3. Uniformity of Weight4. Percentage moisture absorption5. Percentage moisture loss6. In-vitro drug release7. In-vivo drug release8. Accelerated stability studies